読み込み中
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
前日終値
$2.59
+$0.23 · +9.75%
時間外
$2.65
+$0.06 · +2.32%
10月9日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
日中レンジ
現在 $2.59
52週レンジ
現在 $2.59
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
75
割安
センチメント
49
まちまち
リスク
57
やや高いリスク
モメンタム
53
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
日中レンジ
現在 $2.59
52週レンジ
現在 $2.59
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 5284.4万 USD | 4810.2万 USD | 5234.9万 USD | 4451万 USD | 4851.7万 USD |
| 売上原価 | 3381.1万 USD | 1874.2万 USD | 1859万 USD | 1537.9万 USD | 1491.6万 USD |
| 粗利益 | 1903.3万 USD | 2936万 USD | 3375.9万 USD | 2913.1万 USD | 3360.1万 USD |
| 研究開発 | 337.3万 USD | 508万 USD | 484.4万 USD | 454.4万 USD | 432.1万 USD |
| 販売・一般管理 | 3611.7万 USD | 4312.5万 USD | 4886.6万 USD | 4814.9万 USD | 4372.8万 USD |
| 営業費用 | 2547.9万 USD | 4820.5万 USD | 5101.8万 USD | 5269.3万 USD | 4804.9万 USD |
| 受取利息 | 110.8万 USD | 160.6万 USD | 92.1万 USD | 15.7万 USD | 1.1万 USD |
| 支払利息 | 558.9万 USD | 590.7万 USD | 247.8万 USD | 1.5万 USD | 1万 USD |
| 減価償却費と償却費 | 65.5万 USD | 59.9万 USD | 69.2万 USD | 89万 USD | 90.3万 USD |
| 営業利益 | −644.6万 USD | −1884.5万 USD | −1725.9万 USD | −2356.2万 USD | −1444.8万 USD |
| 純利益 | −1121.1万 USD | −2346.3万 USD | −1871.3万 USD | −2318.4万 USD | −1517.2万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI334.13万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Extended Market ETFVXF121.89万0.00%954億 USD0.05%$235+0.80%
iShares Micro-Cap ETFIWC26.94万0.02%13.17億 USD0.60%$183+0.11%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM14万0.12%1.17億 USD0.73%$15.9402+0.25%
Dimensional - US Core Equity 2 ETFDFAC1682.680.00%885.96億 USD0.21%$45.33+0.49%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMDimensional - US Core Equity 2 ETFDFACAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
